Part two of our look at cancer research at VA includes a conversation with Dr. Khalil Ahmend, Professor of Laboratory Medicine and Pathology at the University of Minnesota. Dr. Ahmed has been a Senior Research Career Scientist, Minneapolis VA since 1978. For over forty years, Dr. Ahmed’s long-standing interest has been in protein CK2 (formerly casein kinase 2 or II). He investigation of its therapeutic targeting for cancer therapy and how treatments might be effective for stopping progression to resistant growth or improving response setting the stage for potential ground-breaking translation into the clinic.

Ver todos los episodios